MPS Pharmaa Ltd vs Laurus Labs Limited

A side-by-side comparison of MPS Pharmaa Ltd (531686) and Laurus Labs Limited (LAURUSLABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads 531686 vs LAURUSLABS on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability04
  • Growth· not comparable—
  • Size & financial health13

Valuation

LAURUSLABS takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

-3.70
P/E ratio
125.08
53.27
P/B ratio
19.74
0.00%
Dividend yield
0.10%
₹-0.53
EPS
₹16.47

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-83.08%
Return on equity
16.77%
-13.92%
Return on capital
17.58%
0.00%
EBITDA margin
26.09%
0.00%
Net margin
13.07%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
4.09%
—
Profit CAGR (3Y) even
3.91%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4 Cr
Market cap
₹1.11L Cr
₹0 Cr
Revenue
₹6,813 Cr
₹-1 Cr
Net profit
₹890 Cr
0.00
Debt / equity
0.45
MPS Pharmaa Ltd
  • + []
  • − ["Stock is trading at 56.86 times its book value", "Company has a low return on equity of -90.4% over last 3 years.", "Company reported a net loss of ₹1 Cr in its latest financial year."]
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
MPS Pharmaa Ltd full analysis Laurus Labs Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.